164 related articles for article (PubMed ID: 2730012)
1. [Primary cytoreductive surgery of advanced ovarian cancer with special reference to the significance of bowel resection].
Sato K; Horiguchi M; Kimura M; So E; Kojima T; Tamuna M; Shima Y; Numaguchi M; Uno K; Maru H
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1070-7. PubMed ID: 2730012
[TBL] [Abstract][Full Text] [Related]
2. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS
Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277
[TBL] [Abstract][Full Text] [Related]
3. The role of bowel surgery with cytoreduction for epithelial ovarian cancer.
Cai HB; Zhou YF; Chen HZ; Hou HY
Clin Oncol (R Coll Radiol); 2007 Dec; 19(10):757-62. PubMed ID: 17889517
[TBL] [Abstract][Full Text] [Related]
4. Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy.
Estes JM; Leath CA; Straughn JM; Rocconi RP; Kirby TO; Huh WK; Barnes MN
J Am Coll Surg; 2006 Oct; 203(4):527-32. PubMed ID: 17000397
[TBL] [Abstract][Full Text] [Related]
5. Colon resection for ovarian cancer: intraoperative decisions.
Hoffman MS; Zervose E
Gynecol Oncol; 2008 Nov; 111(2 Suppl):S56-65. PubMed ID: 18835022
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
7. Survival impact of multiple bowel resections in patients undergoing primary cytoreductive surgery for advanced ovarian cancer: a case-control study.
Salani R; Zahurak ML; Santillan A; Giuntoli RL; Bristow RE
Gynecol Oncol; 2007 Dec; 107(3):495-9. PubMed ID: 17854870
[TBL] [Abstract][Full Text] [Related]
8. Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer.
Mourton SM; Temple LK; Abu-Rustum NR; Gemignani ML; Sonoda Y; Bochner BH; Barakat RR; Chi DS
Gynecol Oncol; 2005 Dec; 99(3):608-14. PubMed ID: 16153697
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer.
Munkarah AR; Hallum AV; Morris M; Burke TW; Levenback C; Atkinson EN; Wharton JT; Gershenson DM
Gynecol Oncol; 1997 Jan; 64(1):13-7. PubMed ID: 8995541
[TBL] [Abstract][Full Text] [Related]
10. Surgical indications for combined partial rectosigmoidectomy in ovarian cancer.
Takahashi O; Sato N; Miura Y; Ogawa M; Fujimoto T; Tanaka H; Sato H; Tanaka T
J Obstet Gynaecol Res; 2005 Dec; 31(6):556-61. PubMed ID: 16343259
[TBL] [Abstract][Full Text] [Related]
11. Cytoreductive surgery combined with organ resection for advanced ovarian carcinoma.
Todo Y; Sakuragi N; Oikawa M; Negishi H; Yamamoto R; Yoshiaki K; Tsumura N; Kawaguchi I; Fujimoto S
Int J Clin Oncol; 2003 Apr; 8(2):90-6. PubMed ID: 12720101
[TBL] [Abstract][Full Text] [Related]
12. The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries.
Ayhan A; Guvenal T; Salman MC; Ozyuncu O; Sakinci M; Basaran M
Gynecol Oncol; 2005 Aug; 98(2):235-41. PubMed ID: 15982725
[TBL] [Abstract][Full Text] [Related]
13. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
14. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
[TBL] [Abstract][Full Text] [Related]
15. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer.
Aletti GD; Dowdy SC; Gostout BS; Jones MB; Stanhope CR; Wilson TO; Podratz KC; Cliby WA
Obstet Gynecol; 2006 Jan; 107(1):77-85. PubMed ID: 16394043
[TBL] [Abstract][Full Text] [Related]
16. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC
Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
[TBL] [Abstract][Full Text] [Related]
17. Optimal cytoreductive surgery is an independent prognostic indicator in stage IV epithelial ovarian cancer with hepatic metastases.
Naik R; Nordin A; Cross PA; Hemming D; de Barros Lopes A; Monaghan JM
Gynecol Oncol; 2000 Aug; 78(2):171-5. PubMed ID: 10926798
[TBL] [Abstract][Full Text] [Related]
18. Cytoreductive surgery for stage IV epithelial ovarian cancer.
Zang RY; Zhang ZY; Cai SM; Li ZT; Chen J; Tang MQ; Liu Q
J Exp Clin Cancer Res; 1999 Dec; 18(4):449-54. PubMed ID: 10746968
[TBL] [Abstract][Full Text] [Related]
19. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
[TBL] [Abstract][Full Text] [Related]
20. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.
Tebes SJ; Sayer RA; Palmer JM; Tebes CC; Martino MA; Hoffman MS
Gynecol Oncol; 2007 Sep; 106(3):482-7. PubMed ID: 17590420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
